This digest covers key virtual and digital health regulatory and public policy developments during April and early May 2024 from the United States, United Kingdom, and European Union.
Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more and more frequently. Naturally with more and more people using it for work, new regulations on data use and management are starting to appear.
Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more and more frequently. Naturally with more and more people using it for work, new regulations on data use and management are starting to appear.
This digest covers key virtual and digital health regulatory and public policy developments during October 2023 from the United States, United Kingdom, and European Union.
This digest covers key virtual and digital health regulatory and public policy developments during October 2023 from the United States, United Kingdom, and European Union.